Quadrant Capital Group LLC Has $2.55 Million Stock Holdings in Danaher Corporation $DHR

Quadrant Capital Group LLC lowered its stake in shares of Danaher Corporation (NYSE:DHR) by 20.8% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 12,882 shares of the conglomerate’s stock after selling 3,378 shares during the period. Quadrant Capital Group LLC’s holdings in Danaher were worth $2,545,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in DHR. Red Tortoise LLC raised its stake in Danaher by 175.0% during the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after buying an additional 98 shares during the period. Costello Asset Management INC bought a new stake in shares of Danaher during the first quarter valued at approximately $41,000. Ramirez Asset Management Inc. bought a new stake in shares of Danaher during the second quarter valued at approximately $40,000. Strengthening Families & Communities LLC raised its position in shares of Danaher by 81.4% during the first quarter. Strengthening Families & Communities LLC now owns 254 shares of the conglomerate’s stock worth $52,000 after purchasing an additional 114 shares during the period. Finally, Saudi Central Bank bought a new position in shares of Danaher in the 1st quarter worth $52,000. Institutional investors own 79.05% of the company’s stock.

Insider Activity at Danaher

In related news, Director Teri List sold 3,298 shares of the stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total transaction of $746,997.00. Following the completion of the transaction, the director owned 20,762 shares in the company, valued at approximately $4,702,593. This represents a 13.71% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Georgeann Couchara sold 5,174 shares of Danaher stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $210.42, for a total transaction of $1,088,713.08. Following the completion of the sale, the senior vice president directly owned 2,625 shares in the company, valued at approximately $552,352.50. This represents a 66.34% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 30,248 shares of company stock worth $6,609,663. 11.10% of the stock is owned by company insiders.

Danaher Stock Performance

DHR stock opened at $228.41 on Friday. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.33. The firm has a market cap of $161.33 billion, a PE ratio of 47.09, a P/E/G ratio of 3.28 and a beta of 0.81. The business has a 50 day moving average of $211.54 and a 200-day moving average of $202.99. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $258.23.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Monday, October 20th. The conglomerate reported $1.89 EPS for the quarter, topping analysts’ consensus estimates of $1.72 by $0.17. The business had revenue of $6.05 billion for the quarter, compared to analyst estimates of $6 billion. Danaher had a return on equity of 10.92% and a net margin of 14.44%.Danaher’s quarterly revenue was up 4.4% compared to the same quarter last year. During the same period last year, the company posted $1.71 earnings per share. As a group, sell-side analysts expect that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, October 31st. Investors of record on Friday, September 26th were issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend was Friday, September 26th. Danaher’s payout ratio is 26.39%.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the stock. Weiss Ratings restated a “hold (c-)” rating on shares of Danaher in a research note on Wednesday, October 8th. Wells Fargo & Company reiterated a “positive” rating on shares of Danaher in a report on Thursday, October 23rd. Barclays boosted their target price on shares of Danaher from $225.00 to $250.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 22nd. Robert W. Baird set a $247.00 price target on shares of Danaher in a research report on Wednesday, October 22nd. Finally, TD Cowen lifted their price target on Danaher from $250.00 to $260.00 and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Eighteen equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and a consensus target price of $243.39.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.